Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-Up

5 hours ago 1

U.S. pharma elephantine Bristol-Myers Squibb has struck a concern and licensing woody with Chinese drugmaker Hengrui, successful a woody that could worthy much than $15 billion.

Read Entire Article

Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-Up

Related

Novo Nordisk Says Higher-Dose Wegovy Shot Helps Some Patient...

Supreme Court Continues Access to Abortion Pill by Mail, for...

Cruise Ship Hit by Hantavirus Leaves Canary Islands and Sail...

Popular

5 Takeaways From the Last Televised California Governor Deba...

Electrical fire to keep theater that hosts 'The Book of Morm...

F.D.A. Blocked Publication of Research Finding Covid and Shi...

Kazakhstan strikes gold on day 2 in Astana

Anthropic’s C.E.O. Says It Could Grow by 80 Times This Year